文献速递临床试验与 GCP基础与转化研究

神门与三阴交配伍治疗失眠的随机对照试验研究方案

Acupoint combination effect of Shenmen (HT 7) and Sanyinjiao (SP 6) in treating insomnia: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2020-03-12

BACKGROUND: Insomnia is a global disease with a high incidence and acupuncture therapy is a well appropriate method to treat insomnia. Shenmen (HT 7) and Sanyinjiao (SP 6) are the acupoints most commonly used to treat insomnia.…

要点

  • 神门与三阴交是治疗失眠最常用穴位,但其配伍是否必需及协同或拮抗效应尚不明确。
  • 主要结局为睡眠与情绪量表,次要结局包括多导睡眠图及血清神经递质与代谢标志物。

核心结论

  • 本研究旨在探索神门(HT 7)与三阴交(SP 6)配伍治疗失眠的穴位组合效应及其生物学机制,为针灸临床选穴提供证据。

研究设计与样本

  • 平行组随机对照试验,拟招募120例失眠患者随机分为对照组、神门电针组、三阴交电针组及神门加三阴交电针组,分配比1:1:1:1,每组30例。

关键数值与推荐

  • 主要结局指标包括睡眠功能障碍评定量表、失眠严重程度指数、Epworth嗜睡量表、Zung焦虑自评量表和Zung抑郁自评量表,并结合Measure Your Medical Outcome Profile评估失眠及情绪状态。
  • 次要结局指标包括多导睡眠图监测的睡眠构成以及血清乙酰胆碱、5-羟色胺、多巴胺、去甲肾上腺素、褪黑素、γ-氨基丁酸和代谢生物标志物的测量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Insomnia is a global disease with a high incidence and acupuncture therapy is a well appropriate method to treat insomnia. Shenmen (HT 7) and Sanyinjiao (SP 6) are the acupoints most commonly used to treat insomnia. Although they can obviously relieve the clinical symptoms of insomnia, it is unclear whether they must be used together, whether the combination of two acupoints may have a synergistic or antagonistic effect, and whether there is a primary or secondary relationship between the two points in the treatment of insomnia. Further studies are needed. Therefore, in this study, we are exploring the acupoint combination effect and biological mechanism of HT 7 and SP 6 in treating insomnia. METHODS/DESIGN: This will be a parallel group randomized controlled trial. The study will recruit 120 patients with insomnia randomly assigned to a control group, an electroacupuncture on HT 7 group, an electroacupuncture on SP 6 group, and an electroacupuncture on HT 7 and SP 6 group. The allocation ratio is 1:1:1:1, with 30 subjects in each group. Meanwhile, ten healthy subjects who meet the study criteria will be recruited as the healthy control group. Patients in the intervention groups will be given ten rounds of electroacupuncture stimulation on the corresponding acupoints for 2 weeks, five times per week, with 2 days of rest between the two treatment courses. Patients in the control group will also receive the same two courses of ten rounds of compensatory acupuncture therapy after a 2-week waiting period for treatment. The major outcome measures of this study include the Sleep Dysfunction Rating Scale, the Insomnia Severity Index, Epworth Sleepiness Scale, the Zung Self-Rating Anxiety Scale, and the Zung Self-Rating Depression Scale, combined with the Measure Your Medical Outcome Profile, to evaluate insomnia and the emotional state of patients with insomnia. The secondary outcome measures include sleep composition monitored by polysomnography and measurements of acetylcholine, serotonin, dopamine, norepinephrine, melatonin, gamma-aminobutyric acid, and metabolic biomarkers in serum. DISCUSSION: In this study, we are exploring the acupoint combination effect and biological mechanism of HT 7 and SP 6 in treating insomnia, which may provide evidence for the clinical application of acupuncture and acupoint selection in the treatment of insomnia. TRIAL REGISTRATION: Chinese Clinical Trial Registry, Chi-CTR-1800017483. Registered on 1 August 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wu P, Cheng C, Song X, et al. Acupoint combination effect of Shenmen (HT 7) and Sanyinjiao (SP 6) in treating insomnia: study protocol for a randomized controlled trial. Trials. 2020. PMID: 32164719. doi:10.1186/s13063-020-4170-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。